Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uri S Alon

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Pediatrics|October 16, 2002
Antibiotic treatment and renal stone formation in cystic fibrosisUri S Alon
European Journal of Pediatrics|January 4, 2011
Clinical practice. Fibroblast growth factor (FGF)23: a new hormoneUri S Alon
The Journal of Pediatrics|July 2, 2002
VCUG timingUri S Alon
Pediatric Nephrology (Berlin, Germany)|February 15, 2008
Medical treatment of pediatric urolithiasisUri S Alon
Pediatric Endocrinology Reviews : PER|October 11, 2007
Diseases and clinical applications of the calcium sensing receptorUri S Alon
Pediatric Endocrinology Reviews : PER|May 29, 2018
The Effects of Diuretics on Mineral and Bone MetabolismUri S Alon
Pediatric Nephrology (Berlin, Germany)|July 29, 2003
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitorAnirut Pattaragarn, Uri S Alon
Pediatric Nephrology (Berlin, Germany)|August 16, 2008
Bisphosphonates in children with hypercalciuria and reduced bone mineral densityMichael Freundlich, Uri S Alon
Pediatric Blood & Cancer|January 11, 2013
Magnesium homeostasis and hypomagnesemia in children with malignancyChaim Kaplinsky, Uri S Alon
European Journal of Pediatrics|October 3, 2003
The role of bisphosphonates in diseases of childhoodTarak Srivastava, Uri S Alon
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Pediatrics|October 16, 2002
Antibiotic treatment and renal stone formation in cystic fibrosisUri S Alon
European Journal of Pediatrics|January 4, 2011
Clinical practice. Fibroblast growth factor (FGF)23: a new hormoneUri S Alon
The Journal of Pediatrics|July 2, 2002
VCUG timingUri S Alon
Pediatric Nephrology (Berlin, Germany)|February 15, 2008
Medical treatment of pediatric urolithiasisUri S Alon
Pediatric Endocrinology Reviews : PER|October 11, 2007
Diseases and clinical applications of the calcium sensing receptorUri S Alon
Pediatric Endocrinology Reviews : PER|May 29, 2018
The Effects of Diuretics on Mineral and Bone MetabolismUri S Alon
Pediatric Nephrology (Berlin, Germany)|July 29, 2003
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitorAnirut Pattaragarn, Uri S Alon
Pediatric Nephrology (Berlin, Germany)|August 16, 2008
Bisphosphonates in children with hypercalciuria and reduced bone mineral densityMichael Freundlich, Uri S Alon
Pediatric Blood & Cancer|January 11, 2013
Magnesium homeostasis and hypomagnesemia in children with malignancyChaim Kaplinsky, Uri S Alon
European Journal of Pediatrics|October 3, 2003
The role of bisphosphonates in diseases of childhoodTarak Srivastava, Uri S Alon
Pageof 8